No difference in retinal fluorescence after oral curcumin intake in amyloid‐proven AD cases compared to controls

INTRODUCTION: Previous work has showed the in vivo presence of retinal amyloid in Alzheimer's disease (AD) patients using curcumin. We aimed to replicate these findings in an amyloid biomarker–confirmed cohort. METHODS: Twenty‐six patients with AD (age 66 [+9], Mini‐Mental Status Examination [M...

Descripción completa

Detalles Bibliográficos
Autores principales: den Haan, Jurre, Hart de Ruyter, Frederique J., Lochocki, Benjamin, Kroon, Maurice A.G.M., Kemper, E. Marleen, Teunissen, Charlotte E., van Berckel, Bart, Scheltens, Philip, Hoozemans, Jeroen J., van de Kreeke, Aleid, Verbraak, Frank D., de Boer, Johannes F., Bouwman, Femke H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Diagnostic and Prognostic Assessment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376971/
https://www.ncbi.nlm.nih.gov/pubmed/35991218
http://dx.doi.org/10.1002/dad2.12347

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376971/
https://www.ncbi.nlm.nih.gov/pubmed/35991218
http://dx.doi.org/10.1002/dad2.12347

Ejemplares similares